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Historically, it was thought that the number of X chromosomes plays little role
in causing sex differences in traits. Recently, selected mouse models have been
used increasingly to compare mice with the same type of gonad but with one
versus two copies of the X chromosome. Study of these models demonstrates
that mice with one X chromosome can be strikingly different from those with
two X chromosomes, when the differences are not attributable to confounding
group differences in gonadal hormones. The number of X chromosomes
affects adiposity and metabolic disease, cardiovascular ischaemia/reperfusion
injury and behaviour. The effects of X chromosome number are likely the
result of inherent differences in expression of X genes that escape inactivation,
and are therefore expressed from both X chromosomes in XX mice, resulting
in a higher level of expression when two X chromosomes are present. The
effects of X chromosome number contribute to sex differences in disease
phenotypes, and may explain some features of X chromosome aneuploidies
such as in Turner and Klinefelter syndromes.

1. Introduction
It comes as no surprise to us that males and females are different, because the
differences are emphasized and celebrated in our daily conversations from the
earliest years of our lives. In everyday discourse, biological sex differences are
easily confused with gender differences, i.e. those stemming from cultural
attitudes and sex-specific rearing. The study of biological sex differences attempts
to identify, categorize and understand the inherent factors that make the two sexes
different from each other. These include factors that make every female different
from every male (and vice versa). In addition, some factors cause the two sexes to
be different, on average, even though some individuals of each sex are similar to
individuals of the other sex. Our general goal is to distinguish and understand
the separate components causing sex differences.
At the beginning of life, in the zygote, all inherent components must be
encoded on the X and Y sex chromosomes, because they are the only genetic
factors that are different at that stage. The Y chromosome of mammals encodes
several genes that eventually make males different from females, including the
testis-determining gene Sry and genes required for spermatogenesis [1,2]. The
action of Sry sets up lifelong differences in the levels of gonadal hormones,
which act in each sex to make it different from the other sex. Until recently,
the X chromosome was thought not to participate significantly in the process
of sexual differentiation. That attitude probably stemmed partly from the idea
that the process of X inactivation effectively silences most of one X chromosome
in XX females, so that they, like XY males, have one active X chromosome in
each cell. In the past decade, however, the study of mouse models has provided
convincing evidence that cells with two X chromosomes are intrinsically different from those with one X chromosome. Sex differences caused by the number

& 2016 The Author(s) Published by the Royal Society. All rights reserved.

2. Mechanisms causing sex differences because
of the number of X chromosomes

3. Methods for detecting differential effects
of two versus one X chromosome
Our goal is to test for phenotypic effects of the number of X
chromosomes, mirroring the natural difference between
females and males, in a manner that will reveal X gene effects
involving the molecular mechanisms outlined in §2. We note
that some traditional methods of linking genes to phenotypes
may not uncover these kinds of X chromosome dosage
effects. For example, traditional linkage or association
analyses, which establish that variations in the genomic
sequence cause phenotypic variation, do not test directly
for effects of different doses of genes when there is no difference in genomic DNA sequence. Although variations in
genomic sequence might cause changes in gene expression
that accidentally mimic sex differences in levels of expression,
they do not necessarily do that, and X escapees may have no
endogenous differences in DNA sequence. Moreover, many
linkage and association studies do not include the X chromosome because of the complexity of analysis of that
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The X chromosome is one of the most unusual chromosomes
in mammals, because it is present in different numbers in
males and females. There are numerous ramifications of
this inherent imbalance. The inequality in genomic dose of
X genes is thought to present a major problem [3], but perhaps for only some gene networks [4]. For some genes,
having one or two doses does not make much difference,
so that individuals with a single copy of the gene have
about the same phenotype as those with two expressed
copies. For other X genes, however, the level of expression
must be within a limited range, over which the gene product
has the optimal balance with its interacting partners, most of
which are autosomal [5,6]. These X genes are called ‘dosagesensitive’ genes. The existence of dosage-sensitive genes on
the X chromosome means that cells with two X chromosomes
will have too much of some gene products, and/or cells with
one X chromosome will have too little, relative to their interacting partners in gene networks. This imbalance creates a
selection pressure to increase the expression of the gene in
XY cells, which leads to counteracting pressure to decrease
expression in XX cells. These selection pressures are thought
to have driven the evolution of the current dosage compensation system, X inactivation. The expression of X genes,
from a single X chromosome in both sexes, is also upregulated by an unknown mechanism to make X gene
expression about on a par with expression of autosomal
genes, which are expressed from two copies in most instances
[7]. X inactivation is a remarkable process that quite effectively reduces the expected XX.XY sex difference in
expression of all but a small minority of X genes [8].
Because X inactivation is a random process in somatic tissues derived from the embryonic epiblast, each XX cell
expresses most gene variants and parental imprints from
only one of the two X chromosomes. Adult XX tissues and
individuals are therefore mosaics of cells that exhibit the
effects of either the maternal or paternal X genes. No such
mosaicism occurs in XY tissues. The mosaicism of X gene
effects has long been recognized as one of the factors that
makes individuals with two X chromosomes different from
those with one [9,10]. In general, mosaicism is viewed as
protective against disease, thus benefitting females. If a deleterious X mutation (or imprint) is inherited from the mother,
that mutation is expressed in all cells of XY individuals,
because of the male’s hemizygous exposure of X alleles, but
in only about half of the cells of XX (or XXY) individuals.
Thus, X-linked mutations affect males more than females
(e.g. as in X-linked developmental disabilities such as Fragile
X syndrome). More generally, any genetic variation among X
alleles, even those not causing overt disease (e.g. red-green
colour blindness), will cause sex differences in traits because
the effect of the variant is mitigated in XX tissues by the presence of another variant, but not in XY tissues. The ‘mosaicism

buffering effect’ that causes sex differences is relevant only to
genetically diverse populations such as humans, but is not a
potential explanation of sex differences in traits in inbred
laboratory populations such as inbred mice in which the
maternal and paternal X alleles are identical.
The sexual inequality of number of X chromosomes also
leads to sex differences in traits via at least three mechanisms
other than mosaicism: escape from X-inactivation, X imprinting and epigenetic sinks [11]. (i) Escape from X inactivation. X
inactivation is not 100% complete, because some genes are
insulated from the inactivation process and are thus
expressed from both X chromosomes, making expression
levels inherently greater in XX (and XXY) cells than in XY
(or XO) tissues. The number of ‘X escapees’ has been estimated at about 15% of X genes in humans, and 3% in mice
[12 –15]. These estimates are based on studies of cell lines
under artificial conditions in vitro, in which it is possible to
detect rigorously even small amounts of expression from
the inactive X chromosome. Evidence suggests, however,
that many of the putative X escapees do not show the
expected XX.XY pattern of expression in whole tissues
in vivo [16,17], and the degree of escape from inactivation
might be specific to cell types, developmental stages, disease
states, environmental conditions, etc. [18]. (ii) Parental imprinting. During production of gametes, each parent methylates
DNA in some genes, silencing the allele passed from that
parent to its offspring, a process known as imprinting. Sex
differences in traits might also arise because of the inherently
different pattern of parental imprinting of the X chromosome.
Unlike XY tissues, XX tissues are influenced by parent-oforigin effect on X genes. Each parental imprint affects
expression in about one-half of the cells because of random
X inactivation. For example, a paternal imprint affects only
XX cells in which the paternal X chromosome is active.
(iii) Epigenetic sinks. The presence of a large inactive and
heterochromatic X chromosome in XX cells may attract
heterochromatizing factors away from other chromosomes
( providing a ‘sink’ for those factors) which could shift the
epigenetic status of the genome, and shift gene expression.
The ‘epigenetic sink’ hypothesis is still speculative, but has
some support [19 –23].
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of X chromosomes can have a profound effect on disease. A
fundamental understanding of these diseases requires an
appreciation of the effects of X chromosome number. The
role of the X chromosome implies that specific X genes, at certain levels of expression, protect from disease and therefore
might be novel targets for therapy.

Four Core Genotypes
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Figure 1. Effects of one versus two X chromosomes can be revealed using two mouse models that have various combinations of sex chromosomes and gonad type.
In the FCG model, the Y chromosome is deleted for Sry, and designated Y2. An Sry transgene (S) is present on chromosome 3 in some groups. Breeding XYM with
XXF produces the four genotypes, XX and XY mice with testes (XXM, XYM), and XX and XY mice with ovaries (XXF, XYF). In the XY* model, breeding an XX mother
with XY* father produces the four genotypes, based on the abnormal recombination of the Y* chromosome with the X chromosome [43 – 45]. Adapted from [27]
with permission from Elsevier.

chromosome [24,25]. However, methods that vary the copy
number of the X chromosome to observe its effects in vivo
have been informative [25].
We discuss here mouse models for comparing mice with
different numbers of the X chromosome [26–28], because
this species is the most genetically tractable whole-animal
mammalian model of human physiology and disease. An
important problem is that groups with different numbers of
X chromosomes could conceivably have different levels of
gonadal hormones, so that group differences might be
caused by gonadal hormones rather than direct effects of X
genes on non-gonadal tissues. For example, naturally occurring variation in the number of X chromosomes in humans
is associated with changes in adult gonadal hormone levels.
Women with Turner syndrome (XO) are infertile and have
altered levels of androgens and oestrogens, compared with
XX females [29]. Klinefelter syndrome (KS) men (XXY) are
also infertile and have lower levels of androgens than XY
men [30]. XXY mice similarly are infertile and have lower
levels of androgens compared with XY [31–33], but XY and
XXY male mice appear to have similar levels of androgens prenatally [34]. The endocrine differences between XO and XX
mice are reduced relative to those in humans. XO mice are fertile in some genetic backgrounds, and prenatal levels of
androgens appear to be similar to those of XX mice [34].
Nevertheless, one cannot assume that there are no differences
in the levels of ovarian hormones. Accordingly, methods must
be used to deal with the possible problem that varying X
chromosome number could bring changes in the levels of
gonadal hormones, which cause differences in non-gonadal

traits. Distinguishing hormonal and non-hormonal effects of
X chromosome number is a challenge.
One approach to circumventing the issue of confounding
gonadal hormone levels is to gonadectomize (GDX) mice as
adults (with or without equal hormone replacement) to
control hormone levels, so that groups of adult mice can be
effectively compared when hormonal levels are the same
[35]. Although that method eliminates many possible confounding effects of hormones, it is not sufficient to
eliminate all conceivable group differences caused by gonadal hormones. Gonadal hormone effects can be long-lasting, so
that group differences may exist even before birth, or before
the time of GDX, and can potentially cause phenotypic differences in adulthood [36,37]. (Nevertheless, prenatal
differences in gonadal hormone levels, in mice with the
same type of gonad, have not been detected in two mouse
models discussed here, the Four Core Genotypes (FCG) and
XY* models [34,38].) Ultimately, there are almost no methods
for keeping gonadal hormones equivalent among groups
during the entire lifetime, except in mice that lack gonads
entirely [39–41]. However, as we see in §4, it is possible to
discover differences in mice with different sex chromosomes
that are not explained by effects on gonadal secretions.
One useful model is the FCG model [28,35,42], which produces XX and XY mice with testes (XXM and XYM) or with
ovaries (XXF and XYF) (figure 1). Thus, the XX versus XY
comparison can be made when both groups have testes, or
have ovaries. The XX and XY groups with the same type of
gonad have similar levels of gonadal hormones in adulthood
[46 –50]. Moreover, differences between XX and XY mice are
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(a) Sex differences in metabolism and adiposity
Women and men differ in the amount and distribution of fat in
the body, and overweight and obesity have differential effects
on health of the two sexes [52]. Mice are an important genetic
model in research on obesity and metabolic syndrome. As
adults, male mice generally weigh more than female mice. In
the C57BL/6 strain, the sex difference is approximately 25%.
This difference can be seen in gonad-intact FCG mice
(figure 2a). By 45 days of age, after puberty, XXM or XYM
mice (males with testes) weigh more than XXF and XYF
(females with ovaries). To test if the sex difference is caused
by adult secretions of gonadal hormones, the gonads are
removed (figure 2b). Within a month after GDX, all four
groups weigh about the same, because of reduced increase
of body weight in males and increase in body weight in
females, indicating that the main sex difference in body
weight was influenced by both testicular and ovarian sections
[43,53,55]. In mice gonadectomized for seven weeks or longer,
however, the XX mice gradually gain weight relative to XY
mice, leading to a large XX . XY difference in body weight
by eight months after GDX. This demonstrates that two X
chromosomes are associated with enhanced body weight, a
finding that could never be determined by comparing

(b) Sex differences in cardiovascular disease
Men and women differ in their susceptibility to cardiovascular
artery disease, which is a leading cause of death [60], but the
biological basis of the sex difference is not well understood.
The FCG and XY* mouse models have also been studied in a
mouse model of ischaemia/reperfusion (I/R) injury in the
heart [61] (figure 3) modelling a human heart attack. FCG
and XY* mice were GDX and used one month later to
remove any possible group differences in levels of gonadal hormones. In an in vivo model, blood flow to some regions of the
heart is stopped by ligating one of the cardiac arteries for
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4. Test cases showing effects of X chromosome
number

standard XX female and XY male mice, which differ from
one another in both gonad type and sex chromosome complement. This sex chromosome effect cannot be explained by
group differences in gonadal hormones secreted in adulthood,
because the groups had no gonadal hormones for a prolonged
period of adulthood. The effect is also not likely to have been
caused by group differences in the levels of gonadal hormones
secreted before GDX in adulthood, because the XX.XY difference occurs when comparing XX and XY groups that both had
either testes or ovaries. The sex chromosome effect therefore
occurs robustly under distinctly different hormonal conditions.
Moreover, comparison of XX and XY FCG mice with the same
type of gonad has uncovered no prenatal or adult XX–XY
difference in levels of gonadal hormones [38,46–50].
The XX chromosome effect on body weight could potentially
be caused by the presence of two X chromosomes, or by the
absence of a Y chromosome. To distinguish these possibilities,
mice from the XY* model were studied. In mice gonadectomized
as adults, body weight increased in mice with two X chromosomes (XX and XXY) more than in mice with one X
chromosome (XO or XY), but the presence or absence of the Y
chromosome had little apparent effect (figure 2c) [53]. Thus, the
effect is caused by the inherent sex difference in number of X
chromosomes. The results from XY* mice confirm and extend
those from FCG mice, using a different genetic model.
The X chromosome effect on body weight is associated
with several metabolic changes. One reason for the greater
body weight and adiposity of XX mice, relative to XY,
could be that they begin their diurnal phase of feeding earlier,
and ingest more food during the light phase of the cycle
[53,55]. Thus, the time of food intake, rather than total
amount eaten, could be affected by the number of X chromosomes. Mice with two X chromosomes also have higher
expression of growth hormone mRNA in the arcuate nucleus
of the hypothalamus, which likely reflects different activity of
hypothalamic circuits regulating feeding [56,57]. Mice with
two X chromosomes (relative to those with one) also express
higher levels of the gene Pdyn in the striatum [58], which is
conceivably related to feeding behaviour [59]. The changes
in feeding in XX mice gonadectomized as adults likely
contribute to the accrual of nearly double the levels of body
fat as XY mice [53]. Moreover, when GDX XX mice are fed
a high fat, simple carbohydrate diet, they gain weight faster
than XY mice, develop insulin resistance, and have greatly
elevated levels of liver fat [53]. In addition, XX mice have
altered levels of circulating lipoproteins compared with XY
mice, including about 20% higher levels of high-density
lipoproteins, both when they are gonad-intact and after
GDX, and when fed different diets (figure 2d) [54]. Again,
this difference is attributable to the number of X chromosomes.

rstb.royalsocietypublishing.org

found after the gonads are removed in adulthood (making
their adult gonadal hormone levels zero, and equivalent
across groups). In some cases, the XX versus XY difference
observed in mice with ovaries is similar to the XX versus
XY difference observed in mice with testes. That result
suggests that sex chromosome differences can occur under
quite different hormonal conditions including during prenatal life (see examples in §4). The FCG model has the major
advantage that it detects XX versus XY differences that are
independent of type of gonad. The model does not solve
whether these sex chromosome effects are caused by the
number of X chromosomes (1 versus 2) or the presence of
the Y chromosome. For that purpose, the XY* model is
useful. It compares groups that have sex chromosomes that
are similar to XO, XX, XY and XXY (figure 1). In this
model, two comparisons test for different effects of one
versus two X chromosomes: XO versus XX, and XY versus
XXY (figure 1). The combined use of the FCG and XY*
models offers the advantage that a sex chromosome effect
can be detected and found to be insensitive to gonadal type
in the FCG model, and then confirmed in a completely different genetic model using XY* mice, which also discriminates
between effects caused by X or Y chromosome number. The
XY* model may be used by itself, to demonstrate differences
in the effects of one versus two X chromosomes, in the presence (XY versus XXY) or absence (XO versus XX) of the Y
chromosome [51]. The XY* model also tests for the effect of
a Y chromosome (XO versus XY or XX versus XXY), but in
this model the Y chromosome effects are most likely the
result of effects of testicular secretions, because the mice
with Y chromosomes have testes. In §4(a– c), we illustrate
the use of these and related mouse models to identify mechanisms that contribute to sex differences in traits such as
obesity, cardiovascular disease and behaviour.
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Figure 2. The FCG and XY* models are used to demonstrate that the number of X chromosomes contributes to sex differences in body weight and lipoprotein levels.
(a) At weaning (age 21 days), the FCG groups have similar body weight, but after puberty (day 45), mice with testes had greater body weight than mice with
ovaries (‡p , 0.000001), and mice with XX sex chromosomes weighed slightly more than XY (*p , 0.05). After mice were gonadectomized (GDX) at 75 days of
age, and allowed to grow for 10 months, XX mice weighed much more than XY mice, in both gonadal male groups and gonadal female groups (†p , 0.0001), and
females were heavier than males (**p , 0.01). The effects of sex chromosome complement interacted significantly with the effects of gonad type (int, *p , 0.05).
(b) Growth curves for FCG mice GDX at day 75 (week 0). Before gonadectomy (GDX), mice with ovaries weighed less than mice with testes, and XX mice weighed
more than XY mice. The sex difference caused by gonadal secretions acting in adulthood disappeared within four to five weeks after GDX, and thereafter XX mice
gained more weight than XY mice. (c) The sex chromosome effect on body weight is confirmed in the XY* model and found to be caused by the number
of X chromosomes, using the same GDX design as in a and b. After GDX at day 75, mice with two X chromosomes gained weight more than mice with
one X chromosome ( p , 0.000001). (d ) Metabolic effects of X chromosome number. In FCG mice (left and centre panels) that were gonad-intact or GDX,
and in mice eating low-fat lab chow or a high cholesterol diet, XX mice had consistently higher plasma levels of high-density lipoprotein (HDL) cholesterol,
independent of their gonadal sex. In the XY* model, mice with two X chromosome had higher HDL levels than mice with one X chromosome. *p , 0.05,
**p , 0.01, ***p , 0.001, †p , 0.0001. Adapted from [53,54], with permission from Wolters Kluwer Health, Inc.
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Figure 3. Use of the FCG model shows that after ischaemia/reperfusion injury, GDX XX mice have worse recovery and larger myocardial infarct area compared with
GDX XY mice, irrespective of gonadal type. (a) Experimental protocol in vivo: the left anterior descending artery was occluded in GDX FCG mice for 30 min followed
by 24 h of reperfusion. (b) Representative cross sections of heart muscle stained with triphenyl tetrazolium chloride. The white area represents the infarcted area,
blue shows the non-infarcted area, red plus white areas show risk area. (c) Percentage of area at risk (AAR) divided by left ventricle area. (d ) Infarct size (IS) divided
by AAR. **p , 0.01, n ¼ 6– 7. (e) Experimental protocol ex vivo: perfusion of the heart is shut off for 30 min, then reperfused for 60 min before measuring heart
function. (f ) The rate pressure product (RPP), a measure of recovery after injury, was worse in XX than XY mice. **p , 0.01. (g) Use of the XY* model shows that
in the ex vivo system, mice with two X chromosomes (XX, XXY) have worse recovery (lower RPP) than mice with one X chromosome (XO, XY). (h) The infarct size as
the percentage of total ventricular area in hearts ex vivo. *p , 0.05. Adapted from [61] with permission from Oxford University Press.
30 min, then the ligature is removed to start the blood flow to
the heart muscle for 24 h, producing I/R injury (figure 3a–d).
In an ex vivo model, in which the heart is removed from the
mouse and perfused through the aorta with an oxygenated
physiological buffer, the flow is interrupted for 30 min
and then restarted for 60 min to simulate I/R injury in
humans (figure 3e–h). In both in vivo and ex vivo models, the
infarct size was measured at the end of the experiment. In the
ex vivo model, haemodynamic parameters were measured
throughout the experiment such as rate pressure product
(RPP). The infarct size in GDX FCG mice was strikingly greater
in XX than XY (approx. 40%) in the in vivo model, independent
of the gonadal sex in mice (figure 3b–d). Consistent with larger
infarct size in XX mice in vivo, the heart functional recovery
after ischaemia in the ex vivo model was significantly lower in
XX than XY mice in GDX FCG mice, as indicated by RPP
(figure 3f ). When the XY* model was subjected to ex vivo I/R
injury, RPP was significantly lower and the infarct size was significantly larger in mice with two X chromosomes, relative to
mice with one X chromosome, and the presence of the Y
chromosome appeared to have no effect (figure 3g,h). These
studies of X chromosome effects on cardiovascular disease
mirror the studies on metabolism discussed in §4(a), in that
two X chromosomes confer a greater disease burden than one
X chromosome.

(c) Sex differences in behaviour
Studies of mouse behaviour also provide evidence that the
number of X chromosomes contributes to sex differences.

Fear reactivity in gonad-intact adult mice is greater in XO
than XX mice, shown by the reluctance of the mouse to venture into an open area of an elevated plus maze. This
difference is not explained by the number of genes in the
pseudoautosomal region (PAR), but by the difference in
number of non-PAR X genes [62]. In studies of sexual behaviour, when mice of the XY* model are GDX as adults and
treated equally with testosterone, then tested with a receptive
female, they show male sex behaviour differently depending
on the number of X chromosomes [34]. In juvenile mice of the
XY* model tested at approximately three weeks of age, mice
with one X chromosome show less social behaviour when
paired with another mouse, compared with mice with two
X chromosomes [51]. Mice with one X chromosome investigated their cage partners more frequently than mice with
two X chromosomes, but spent less total time in proximity
to or interacting with the partner. When tested for preference
for a novel versus familiar mouse, mice with two X chromosomes had greater preference for the unfamiliar mouse. The
greater anxiety-like behaviour, found in adult mice with
one X chromosome [62], was also found in juvenile mice
[51], and may help explain the tendency of mice with one X
chromosome to avoid novel mice or social partners, more
than mice with two X chromosomes.

(d) Models of sex chromosome aneuploidy
The effects of two versus one X chromosome are not only
relevant to the natural difference between the sexes (XX
versus XY), but also to two sex chromosome aneuploidies
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5. Candidate X genes that cause sex differences
The inherent sexual imbalance in the number of X chromosomes has now been shown to have unexpectedly large
effects on phenotypes, including susceptibility to disease.
The next step is to identify the X genes that contribute to
this imbalance, and to understand the downstream pathways
that affect phenotypes. Although the X chromosome is large
and gene-rich, the candidate genes are less numerous, because
we can focus on either imprinted genes or genes escaping X
inactivation. Tissue-specific parent-of-origin effects on gene
expression are just now being reported for an increasing
number of X genes [84–86], but it is not clear how many
of these will emerge as viable candidates for explaining
phenotypic sex differences caused by different number of
X chromosomes. By contrast, the number of X escapees resulting in sex differences in expression is relatively small [13],
making their analysis more tractable and attractive at present.
In mice, several X escapee genes are particularly interesting:
Kdm5c, Kdm6a, Eif2s3x and Ddx3x. These are routinely found
by numerous laboratories to be expressed at higher levels in
XX (or XXY) than XY (or XO) mice in numerous tissues
[53,56,61,73,74,87–92]. Each escapes X chromosome inactivation in humans and mice [93–97]. Two of these genes,
Kdm5c and Kdm6a, are histone demethylases that are expected
to have widespread effects on gene expression throughout the
genome, and null mutations of each are implicated in human
disease [98,99]. Ddx3x is an RNA helicase involved in several
basic cellular processes such as transcription, RNA transport
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Recently, we introduced a novel model of KS, the ‘Sex
Chromosome Trisomy’ (SCT) model, which produces XX,
XY, XXY and XYY mice (figure 4a) [77,83]. In this model, as
in the FCG model, the Sry gene is not on the Y chromosome,
but is present on an autosome as a transgene. Thus, each of the
four sex chromosome groups is produced with Sry (with
testes) or without Sry (with ovaries). The comparison of XXY
groups, modelling KS versus normal men, tests for the effects
of one versus two X chromosomes when a Y chromosome is
present. The model expands the ability to detect effects of
the second X chromosome that do not depend on testicular
secretions, because the model tests the effects also in mice
that do not have testes. In SCT mice GDX as adults and then
treated equally with testosterone, XXY mice weigh more
than XY mice and have more body fat and less lean mass, compared with XY mice (figure 4b) [77]. The occurrence of these
differences in mice that had either testes or ovaries indicates
that the group differences do not depend on XXY versus XY
differences in the levels of testicular hormones. In tests of
sexual partner preference of SCT mice, again GDX and treated
with testosterone, XXY male mice also spent less time with a
female test mouse than did XY male mice, suggesting a feminizing influence of the second X chromosome on sexual partner
preference [83]. This influence appeared to be dependent on
the presence of the Y, as the partner preference of XX male
mice did not differ from XY males. In the same mice, gene
expression was measured in the bed nucleus of the stria
terminalis and the striatum. Most genes in XXY males were
found to be male-typical in their expression patterns, but a
substantial minority of genes in both regions was significantly
more female-typical. These genes are candidates for genetic
contributors to the KS phenotype

rstb.royalsocietypublishing.org

that occur with significant frequency in humans: XO (Turner
syndrome, 1/2500 live female births) and XXY (KS, 1/600
live male births). XO females differ from XX females exclusively because of the difference in number of X
chromosomes, and XXY males differ from normal XY males
for the same reason. XXY males experience inactivation of
one of the two X chromosomes, as in XX females [63]. Monosomy of the X chromosome (XO) is usually lethal to human
embryos [64], but those who survive to adulthood have multiple phenotypes including ovarian failure with abnormal
levels of reproductive hormones (low oestrogen and elevated
androgens), short stature, neck webbing, and susceptibility to
cardiovascular and metabolic disease [29]. Men with KS have
small testes, lowered testosterone levels, and increased
height. As a group they show greater incidence of behavioural problems including delayed language development and
deficits in social and executive functioning [65]. They experience increased prevalence of several health problems [66,67],
some of which are usually more common in women than in
men including breast cancer [68,69], osteoporosis [70] and
autoimmune diseases including rheumatoid arthritis and systemic lupus erythematosus [71]. KS men have increased body
fat, specifically abdominal fat, as well as increased rates of
hyperinsulinaemia, insulin resistance, type II diabetes and
metabolic syndrome [30].
The loss of one X chromosome in female mice results in a
much milder phenotype than in humans. XO mice are fertile at
least in outbred genetic backgrounds. The milder phenotype
might result from a smaller number of genes in the mouse
PAR than human PAR, which are expected to be expressed differently in XO (one PAR) versus XX (two PARs). In addition,
fewer X genes escape inactivation in mice than humans,
which would reduce the presumed disparity of expression
levels of non-PAR X escapees [72], so fewer phenotypes
would be affected. Differences in gene expression have been
detected in XO mice relative to XX, including in X escapees
[73,74]. Although XO mice do not completely model Turner
syndrome, numerous genes escape X inactivation in both
species, so that the XX versus XO comparison in mice may
well model some effects of dosage of those genes in humans.
Several mouse models of KS have been used [33,75–77].
These studies have demonstrated that the second X chromosome
in males eliminates sperm production as in KS men [78], reduces
testis size, lowers testosterone levels, induces Leydig cell hyperplasia and causes behavioural deficits [33,79]. Moreover, XXY
mice have abnormal bone density, and altered sexual partner
preferences [80,81]. In most of these studies, gonad-intact mice
were studied, so that the lower levels of testosterone in XXY
mice, relative to XY mice, could have caused the difference in
phenotype, instead of direct (non-gonadal) effects of X genes
in mice with one versus two X chromosomes. In some cases,
the group differences in adult levels of testosterone were eliminated by castration of adult males, with or without
replacement of testosterone [34,80–82]. For some behaviour
traits, such as altered social interaction and sex preference, equalizing hormone levels ameliorated group differences [81].
However, differences in male sexual behaviour and in bone
architecture persisted despite castration and testosterone replacement [34,80]. These studies ruled out effects of circulating
testosterone as the responsible mechanism, but in these studies
it is difficult to assess if XY versus XXY differences in levels of
testicular hormones before the time of GDX contributed to
group differences in phenotype.

(a) Sex Chromosome Trisomy mouse model
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Figure 4. The Sex Chromosome Trisomy model. (a) The model involves crossing FCG XY ¯(Sryþ) male (same as XYM in figure 1) with XXY ¯ female who has the
same Y ¯ as in the FCG model (figure 1). The father’s Sry is transgenic on chromosome 3. Eight genotypes are produced, XX, XY, XXY and XYY, each with either testes
or ovaries. (b) Body weight data from SCT mice shows that after gonadectomy (GDX) in adulthood and treatment with testosterone (T), XXY mice weigh more (b)
and have more body fat relative to body weight (c), compared with XY mice. Adapted from [77,83].
and splicing, and translation, and is implicated in human
cancer and intellectual disability [100]. Less is known about
Eif2s3x, a translation initiation factor, which is the X-linked
paralogue of Eif2s3y, a spermatogonial proliferation factor
[101]. Each of these genes has a closely related gene on the Y
chromosome, the expression of which in XY males could compensate for the lack of a second copy of the X gene in males.
However, the Y genes are unlikely to offset sex differences in
effects of X escapees. In some cases, the X and Y copies
appear to have diverged in function [102] or pattern of
expression [89,90], suggesting that the compensation by the
Y paralogue is not complete. Thus, the X escapee genes
remain exciting candidates for explaining the effects of two
X chromosomes relative to one. Tests of this idea require careful manipulation of the dose of the genes in mouse models, to
determine if one versus two copies of the gene causes phenotypic changes similar to the comparison of one versus two
copies of the entire X chromosome.

differences in phenotypes. Their effect was so pervasive that
they were essentially the only proximate factors incorporated
into theories of the origins of sex differences in phenotype.
In the past two decades, however, the sexual imbalance of
effects of the X and Y chromosomes have been clearly
shown to cause sex differences in non-gonadal tissues that
are not mediated by gonadal hormones [10,11,35,103–105].
More of these effects have been localized to the X chromosome
than to the Y chromosome. Although specific X genes are
prime candidates for these effects, we cannot rule out nongenic effects of the X chromosome as reviewed above. These
studies are still in their infancy, because we do not know yet
which X genes are responsible, and how they act. An important question that is almost completely unstudied is how the
multiple sex-biasing factors, hormones and sex chromosome
genes, interact with each other in specific instances. Thus, we
can expect exciting developments in the near future.
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6. Conclusion and prospectus
In the twentieth century, gonadal hormones emerged as the
primary proximate factors that act on tissues to cause sex
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